ARase Therapeutics

ARase Therapeutics is a biotechnology company dedicated to developing innovative therapies targeting ADP-ribosyl hydrolases. The ADP-ribosyl hydrolase family plays a crucial role in cancer-related cellular stress pathways, and this class of enzymes represents a promising new therapeutic target for DNA damage and replication, effective against various tumors with DNA damage repair deficiencies.